UNSPSC 51281650: Gentamicin c1a

This classification denotes an aminoglycoside antibiotic C19H39N5O7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier AV4A72IATD, chemically known as d-streptamine, o-3-deoxy-4-c-methyl-3-(methylamino)-.beta.-l-arabinopyranosyl-(1->6)-o-(2,6-diamino-2,3,4,6-tetradeoxy-.alpha.-d-erythro-hexopyranosyl-(1->4))-2-deoxy-, but more generally known as gentamicin c1a, which bears US NIH Compound Identifier 72396. Most nations, for tariff and trade purposes, schedule gentamicin c1a under HS 29419000 and SITC 54139.

As of Q4 2014, GENTAMICIN C1A remains US FDA's Preferred Term for this commodity. Gentamicin c1a bears US NLM identifiers UMLS ID C1563655 and NCI Concept Code C76149. SMILES: C[C@@]1(CO[C@@H]([C@@H]([C@H]1NC)O)O[C@H]2[C@@H](C[C@@H]([C@H]([C@@H]2O)O[C@@H]3[C@@H](CC[C@H](O3)CN)N)N)N)O.

UNSPSC 51281650 Gentamicin c1a is a Commodity code for a specific antibiotic pharmaceutical product, but the recent state and local opportunities tagged under it do not reflect purchases of gentamicin itself. Instead, the code appears to capture broader pharmaceutical procurement activity at the state and county level, including antibiotic tablets, naloxone, and drug deactivation systems sourced through competitive bidding and cooperative purchasing vehicles. State and local health departments and county government health and emergency management functions are the primary issuing bodies, procuring these pharmaceuticals to support public health initiatives, disease prevention, emergency response, and community health programs.

The geographic spread reflects activity in Illinois and Florida. The Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract to Chartwell Rx LLC on August 28, 2026, through the MMCAP Infuse cooperative purchasing consortium, covering the supply of Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets at $2,999,999.11 over a 12-month initial term with two renewal options. Seminole County, Florida released a competitive bid (IFB 60459723LAS) on June 30, 2026, for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford; the response deadline was July 26, 2026, at 2:00 pm. Cooperative purchasing and IFB processes are the dominant procurement vehicles under this code. Neither recent opportunity explicitly identified set-aside designations for disadvantaged business enterprises.